| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/05/2010 | US20100197729 Therapeutic ((phenyl)imidazolyl)methylquinolinyl compounds |
| 08/05/2010 | US20100197728 Crystalline form of a quinolinone-carboxamide compound |
| 08/05/2010 | US20100197727 Quinoline Derivatives as Antibacterial Agents |
| 08/05/2010 | US20100197726 Inhibitor of the differentiation of t cells into th1 cells |
| 08/05/2010 | US20100197725 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof |
| 08/05/2010 | US20100197724 6.5 -pyrrolopiperidine tachykinin receptor antagonists |
| 08/05/2010 | US20100197723 Bicyclic compounds and methods of making and using same |
| 08/05/2010 | US20100197722 Treatment for basal cell carcinoma |
| 08/05/2010 | US20100197721 PYRROLO [3, 4-h] ISOQUINOLINE COMPOUNDS AND METHODS FOR MODULATING GATED ION CHANNELS |
| 08/05/2010 | US20100197720 Heteroaryl-substituted diazatricycloalkanes and methods of use thereof |
| 08/05/2010 | US20100197719 Medicament compositions containing anticholinergically-effective compounds and betamimetics |
| 08/05/2010 | US20100197718 Treatment of pediatric tumors |
| 08/05/2010 | US20100197717 Treatment of pain, neuropathic pain, sleep disorders, psychological disorders, memory disorders, depression, jet lag; 5HT7 receptor ligand such as AS-19, aka (2S)-(+)-8-(1,3,5-trimethylpyrazolin-4-yl)-2-(dimethylamino)tetralin and opioid such as morphine |
| 08/05/2010 | US20100197716 N-linked heterocyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 08/05/2010 | US20100197715 Piperidine derivatives |
| 08/05/2010 | US20100197714 Spiro-pyrano-pyrazole derivatives |
| 08/05/2010 | US20100197713 Butone derivatives useful as cooling agents |
| 08/05/2010 | US20100197712 Use of dopamine stabilizers |
| 08/05/2010 | US20100197711 Benzothiazole compounds |
| 08/05/2010 | US20100197710 Methods Of Activating IRS-1 And AKT |
| 08/05/2010 | US20100197709 Non-sedating barbiturate compounds as neuroprotective agents |
| 08/05/2010 | US20100197708 Indole compounds |
| 08/05/2010 | US20100197707 Platelet manipulation to reduce the incidence of and treat endovascular disease and its sequelae, to reduce the incidence of and treat arrhythmias and to reduce the incidence of malignancy |
| 08/05/2010 | US20100197706 Derivatives of 1-oxo-1,2-dihydroisoquinoline-5-carboxamides and of 4-oxo-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics |
| 08/05/2010 | US20100197705 Quinazolinone Derivatives Useful as Vanilloid Antagonists |
| 08/05/2010 | US20100197704 Pharmaceutical compositions and method for treating acute mania |
| 08/05/2010 | US20100197703 N-sulfonyl thiazolylpiperazine derivatives and related n-sulfonyl heterocyclic derivatives for the treatment of neuro degenerative diseases |
| 08/05/2010 | US20100197702 Ophthalmic composition with nitric oxide donor compound and method of forming and using same |
| 08/05/2010 | US20100197701 Method of treating diabetes |
| 08/05/2010 | US20100197700 5-ht7 receptor antagonists |
| 08/05/2010 | US20100197699 I-OXA-3-Azaspiro (4.5) Decan-2-One And 1-OXA-3, 8-Diazaspiro (4.5) Decan-2-One Derivatives For The Treatment of Eating Disorders |
| 08/05/2010 | US20100197698 5-phenyl-3-pyridazinone derivative |
| 08/05/2010 | US20100197697 Piperidine derivatives as nk3 receptor antagonists |
| 08/05/2010 | US20100197695 Antitumoral derivatives of et-743 |
| 08/05/2010 | US20100197694 Compositions and methods for treatment of diseases and conditions with increased vascular permeability |
| 08/05/2010 | US20100197693 Novel benzenesulfonamides as calcium channel blockers |
| 08/05/2010 | US20100197692 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 08/05/2010 | US20100197691 Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment |
| 08/05/2010 | US20100197690 Pyrimidinyl Pyridazinone Derivatives |
| 08/05/2010 | US20100197689 Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives |
| 08/05/2010 | US20100197688 Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancer |
| 08/05/2010 | US20100197687 Indoles Useful in the Treatment of Inflammation |
| 08/05/2010 | US20100197686 Therapeutic compounds |
| 08/05/2010 | US20100197685 Novel benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof |
| 08/05/2010 | US20100197684 Substituted heterocyclic compounds |
| 08/05/2010 | US20100197683 Fused ring compound and use thereof |
| 08/05/2010 | US20100197682 Organic Compounds |
| 08/05/2010 | US20100197681 Triazolopyridine Compounds and Their Use as Ask Inhibitors |
| 08/05/2010 | US20100197680 Lactam-substituted dicarboxylic acids and use thereof |
| 08/05/2010 | US20100197679 Compounds |
| 08/05/2010 | US20100197678 Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof |
| 08/05/2010 | US20100197677 Oxadiazoanthracene compounds for the treatment of diabetes |
| 08/05/2010 | US20100197676 5-Substituted-2-Phenylamino Benzamides as Mek Inhibitors |
| 08/05/2010 | US20100197675 Cyclic urea and carbamate inhibitors of 11 beta-hydroxysteroid dehydrogenase 1 |
| 08/05/2010 | US20100197673 Indole and indazole compounds as an inhibitor of cellular necrosis |
| 08/05/2010 | US20100197672 Pyrrole compounds as inhibitors of mycobacteria, synthesis thereof and intermediates thereto |
| 08/05/2010 | US20100197671 Phenyl amino pyrimidine compounds and uses thereof |
| 08/05/2010 | US20100197670 Amidine, thiourea and guanidine derivatives of 2-aminobenzothiazoles and aminobenzothiazines for their use as pharmacological agents for the treatment of neurodegenerative pathologies |
| 08/05/2010 | US20100197669 Kappa selective opioid receptor antagonist |
| 08/05/2010 | US20100197668 1,2,3,4-TETRAHYDROPYRROLO[1,2-A]PYRAZINE-6-CARBOXAMIDE AND 2,3,4,5-TETRAHYDROPYRROLO[1,2-a][1,4]-DIAZEPINE-7-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF |
| 08/05/2010 | US20100197667 Biphenyl compounds useful as muscarinic receptor antagonists |
| 08/05/2010 | US20100197666 (thio) -carbamoyl-cyclohexane derivatives and method for treating schizophrenia |
| 08/05/2010 | US20100197665 Indazole derivatives as kinase inhibitors for the treatment of cancer |
| 08/05/2010 | US20100197664 Novel b1-antagonists |
| 08/05/2010 | US20100197663 Method and compositions for treatment of painful disorders |
| 08/05/2010 | US20100197662 Heterocyclic compound having type i 11 beta hydroxysteroid dehydrogenase inhibitory activity |
| 08/05/2010 | US20100197661 Method of Treating Neurological Diseases and Disorders |
| 08/05/2010 | US20100197660 Azepine derivatives as gamma-secretase inhibitors |
| 08/05/2010 | US20100197659 Biphenylcarboxamide derivatives as hedgehod pathway modulators |
| 08/05/2010 | US20100197658 Pharmaceutical use of fused 1,2,4-triazoles |
| 08/05/2010 | US20100197657 2-aryl or heteroaryl indole derivatives |
| 08/05/2010 | US20100197656 Compounds for the treatment of inflammatory diseases |
| 08/05/2010 | US20100197655 Sulfonamide derivatives |
| 08/05/2010 | US20100197654 Triazine kinase inhibitors |
| 08/05/2010 | US20100197653 Novel carbapenem derivatives |
| 08/05/2010 | US20100197652 Pyridine carboxamide orexin receptor antagonists |
| 08/05/2010 | US20100197651 Pyridazinone compounds |
| 08/05/2010 | US20100197650 Compositions and methods of treatment comprising ceftaroline |
| 08/05/2010 | US20100197649 Compositions and Methods for Diagnosing and Treating Community-Acquired Methicillin-Resistant Staphylococcus Aureus |
| 08/05/2010 | US20100197648 Treatment of irritable bowel syndrome and related bowel disease |
| 08/05/2010 | US20100197647 Compounds that inhibit oestrone sulphatase; compositions thereof; and methods employing the same |
| 08/05/2010 | US20100197646 Solvent-based sterilisation of pharmaceuticals |
| 08/05/2010 | US20100197645 Thioamide Derivatives as Progesterone Receptor Modulators |
| 08/05/2010 | US20100197644 Chemical Compounds 572 |
| 08/05/2010 | US20100197643 Phytochemical-rich oils and methods related thereto |
| 08/05/2010 | US20100197642 Slow release misoprostol for obstetric and/or gynaecological applications |
| 08/05/2010 | US20100197641 Formulation for lipophilic agents |
| 08/05/2010 | US20100197640 Novel sulfamoyl-phenyl-ureido compounds and their use as medicament |
| 08/05/2010 | US20100197639 Methods and Devices for Analysis of X-Ray Images |
| 08/05/2010 | US20100197638 Skin Beautifying Agent |
| 08/05/2010 | US20100197637 Method of Treatment Using Bisphosphonic Acid |
| 08/05/2010 | US20100197636 Injectable calcium-phosphate cement releasing a bone resorption inhibitor |
| 08/05/2010 | US20100197635 Treatment of tardive dyskinesia with pyridoxal 5'-phosphate |
| 08/05/2010 | US20100197634 Inhibitors of janus kinases |
| 08/05/2010 | US20100197632 Anti-inflammatory dermatological composition comprising corticosteroids and hyaluronate fragments, and uses thereof |
| 08/05/2010 | US20100197631 Hyaluronic acid derivatives containing groups able to release no |
| 08/05/2010 | US20100197630 Cetp inhibitors derived from benzoxazole arylamides |
| 08/05/2010 | US20100197629 Oral pharmaceutical solutions containing telbivudine |
| 08/05/2010 | US20100197628 Methods of treating psychiatric, substance abuse, and other disorders using combinations containing omega-3 fatty acids |
| 08/05/2010 | US20100197627 Pancreatic cancer treatment |